Summary
The levels of Acid and Alkaline DNases were measured in the serum of patients with: (a) Cancer of the Genitourinary Tract (confirmed by biopsy), (b) with inflamatory diseases and non-malignant tumours of the Genitourinary tract, (c) healthy blood donors. In the first group the results showed that the Acid DNase level was raised in 62% and Alkaline DNase in 43%. In the second group acid DNase was increased in 30% and Alkaline DNase in 13%. In the third group Acid and Alkaline DNase levels were normal. These results suggest that the measurement of Acid and Alkaline DNases could be considered as malignant diseases markers, in spite of false positive and false negative results in some cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kottel RH (1978) Serum ribonuclease activity in cancer patients. Br J Cancer 38:280–286
Lokich JJ (1978) Tumour markers: Hormones, antigens, and enzymes in malignant diseases. Oncology 35:54–57
Peterson LM (1979) Serum RNase in the diagnosis of pancreatic carcinoma. Biochemistry 76:2630–2634
Schwartz MK (1976) Laboratory acids to diganosis-enzymes. Cancer 37:542–548
Schwartz MK (1973) Enzymes in cancer. Clin Chem 19:10–22
Wahen B (1979) Tumour markers in urology: Acids in cancer diagnosis and management. Urol Res 7:57–67
Author information
Authors and Affiliations
Additional information
Director: C. Dimopoulos
Rights and permissions
About this article
Cite this article
Lykourinas, M., Constantinidis, C., Spantidos, A. et al. The role of Acid and Alkaline DNases as tumour markers in cancer of the genitourinary tract. Urol. Res. 10, 67–70 (1982). https://doi.org/10.1007/BF00262404
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00262404